Exploring The Capability And Potential Of Genetically Targeted Technology
- This event has passed.
March 5, 2025 @ 8:30 am - 10:00 am EST
RNA therapies are a new class of medications that use RNA, a type of genetic material, to treat or prevent diseases. RNA therapies are being developed for a range of conditions, including rare diseases, and are expected to play a key role in the development of new treatments in the future.
Join hosts for a Capitol Hill breakfast briefing, where they will explore the powerful potential of genetically targeted technology and the profoundly important impact of such RNA-based therapies as antisense oligonucleotides (ASO) and RNAi on treatment and prevention. Panelists will discuss the science behind these therapies, the extraordinary capability they hold to address urgent unmet medical needs, and challenges and opportunities bearing on the future of this transformative area of research & development. Space is limited, so secure your spot today!
SWHR CEO Kathryn Schubert will be speaking at this event!